The increasing use of ECMO ensures that we, our patients, and their surrogates will increasingly face difficult decisions regarding the most appropriate use and limitations of this technology. We must make every effort to assess the values and goals of the patient, to communicate prognosis for survival and quality of life, to involve patients, families, and our multidisciplinary teams, and to provide emotional and spiritual support for all involved. We must approach individual clinical scenarios with great deliberation, yet it is clear that the advent of new technologies should not fundamentally change our ethical approach to our patients

Treatment limitations in the era of ECMO / Daniel, Brodie; Randall Curtis, J.; Jean-Louis, Vincent; Jan, Bakker; Brown, Crystal E.; Jacques, Creteur; Laurent, Papazian; Sladen, Robert N.; Marco Ranieri, V.; on behalf of participants in the Round Table Conference, ; Laurent, Brochard; Michael, Broome; Alain, Combes; Daniel De Backer, ; Niall, Ferguson; Luciano, Gattinoi; John, Laffey; Roberto, Lorusso; Alain, Mercat; Nava, Stefano; Antonio, Pesenti; Michael, Quintel; Peter, Rimensberger; Claudio, Ronco; Arthur, Slutsky; Thomas, Staudinger; Fabio, Taccone. - In: THE LANCET RESPIRATORY MEDICINE. - ISSN 2213-2600. - STAMPA. - 5:10(2017), pp. 769-770. [10.1016/S2213-2600(17)30263-1]

Treatment limitations in the era of ECMO

V. Marco Ranieri;Stefano Nava;
2017

Abstract

The increasing use of ECMO ensures that we, our patients, and their surrogates will increasingly face difficult decisions regarding the most appropriate use and limitations of this technology. We must make every effort to assess the values and goals of the patient, to communicate prognosis for survival and quality of life, to involve patients, families, and our multidisciplinary teams, and to provide emotional and spiritual support for all involved. We must approach individual clinical scenarios with great deliberation, yet it is clear that the advent of new technologies should not fundamentally change our ethical approach to our patients
2017
Treatment limitations in the era of ECMO / Daniel, Brodie; Randall Curtis, J.; Jean-Louis, Vincent; Jan, Bakker; Brown, Crystal E.; Jacques, Creteur; Laurent, Papazian; Sladen, Robert N.; Marco Ranieri, V.; on behalf of participants in the Round Table Conference, ; Laurent, Brochard; Michael, Broome; Alain, Combes; Daniel De Backer, ; Niall, Ferguson; Luciano, Gattinoi; John, Laffey; Roberto, Lorusso; Alain, Mercat; Nava, Stefano; Antonio, Pesenti; Michael, Quintel; Peter, Rimensberger; Claudio, Ronco; Arthur, Slutsky; Thomas, Staudinger; Fabio, Taccone. - In: THE LANCET RESPIRATORY MEDICINE. - ISSN 2213-2600. - STAMPA. - 5:10(2017), pp. 769-770. [10.1016/S2213-2600(17)30263-1]
Daniel, Brodie; Randall Curtis, J.; Jean-Louis, Vincent; Jan, Bakker; Brown, Crystal E.; Jacques, Creteur; Laurent, Papazian; Sladen, Robert N.; Marco Ranieri, V.; on behalf of participants in the Round Table Conference, ; Laurent, Brochard; Michael, Broome; Alain, Combes; Daniel De Backer, ; Niall, Ferguson; Luciano, Gattinoi; John, Laffey; Roberto, Lorusso; Alain, Mercat; Nava, Stefano; Antonio, Pesenti; Michael, Quintel; Peter, Rimensberger; Claudio, Ronco; Arthur, Slutsky; Thomas, Staudinger; Fabio, Taccone
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/661234
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 16
social impact